RemeGen Co., Ltd.
REGMF
$1.50
-$0.54-26.47%
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 35.48% | 57.86% | 87.18% | 52.32% | 49.93% |
| Total Other Revenue | 36.66% | -39.40% | -- | 54.94% | -98.71% |
| Total Revenue | 36.18% | 56.58% | 87.18% | 52.37% | 49.57% |
| Cost of Revenue | 1.53% | 18.13% | 182.25% | 61.36% | 25.72% |
| Gross Profit | 45.53% | 73.90% | 70.50% | 49.55% | 57.65% |
| SG&A Expenses | 19.87% | -6.10% | 8.19% | 8.74% | 37.66% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 106.74% | 51.97% | 31.61% | -370.95% | 76.08% |
| Total Operating Expenses | 14.04% | 27.49% | 26.74% | 22.10% | 41.20% |
| Operating Income | 10.32% | -8.01% | 3.88% | -8.31% | -33.01% |
| Income Before Tax | 10.04% | -10.01% | -2.70% | -52.29% | -55.32% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 10.04% | -10.01% | -2.70% | -52.29% | -55.32% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 10.04% | -10.01% | -2.70% | -52.29% | -55.32% |
| EBIT | 10.32% | -8.01% | 3.88% | -8.31% | -33.01% |
| EBITDA | 15.84% | -5.23% | 7.59% | -6.19% | -29.51% |
| EPS Basic | 10.45% | -10.51% | -3.19% | -58.15% | -57.68% |
| Normalized Basic EPS | 7.96% | -14.54% | -1.27% | -21.94% | -47.99% |
| EPS Diluted | 10.45% | -10.51% | -3.19% | -58.15% | -57.68% |
| Normalized Diluted EPS | 7.96% | -14.54% | -1.27% | -21.94% | -47.99% |
| Average Basic Shares Outstanding | 0.39% | -0.51% | -0.52% | -3.72% | -1.56% |
| Average Diluted Shares Outstanding | 0.39% | -0.51% | -0.52% | -3.72% | -1.56% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -1.39% | -- | -2.86% | -- | -1.30% |
